Cargando…
Cell Plasticity-Related Phenotypes and Taxanes Resistance in Castration-Resistant Prostate Cancer
The prostatic tumor cells plasticity is involved in resistance to hormone-therapy, allowing these cells to survive despite androgen receptor inhibition. However, its role in taxanes resistance has not been fully established. Gene expression of plasticity-related phenotypes such as epithelial-mesench...
Autores principales: | Jiménez, Natalia, Reig, Òscar, Montalbo, Ruth, Milà-Guasch, Maria, Nadal-Dieste, Lluis, Castellano, Giancarlo, Lozano, Juan José, Victoria, Iván, Font, Albert, Rodriguez-Vida, Alejo, Carles, Joan, Suárez, Cristina, Domènech, Montserrat, Sala-González, Núria, Fernández, Pedro Luis, Rodríguez-Carunchio, Leonardo, Díaz, Sherley, Prat, Aleix, Marín-Aguilera, Mercedes, Mellado, Begoña |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7667288/ https://www.ncbi.nlm.nih.gov/pubmed/33224888 http://dx.doi.org/10.3389/fonc.2020.594023 |
Ejemplares similares
-
Glutamine and Cholesterol Plasma Levels and Clinical Outcomes of Patients with Metastatic Castration-Resistant Prostate Cancer Treated with Taxanes
por: Marín-Aguilera, Mercedes, et al.
Publicado: (2021) -
Androgen Receptor and Its Splicing Variant 7 Expression in Peripheral Blood Mononuclear Cells and in Circulating Tumor Cells in Metastatic Castration-Resistant Prostate Cancer
por: Marín-Aguilera, Mercedes, et al.
Publicado: (2020) -
ERG induces taxane resistance in castration-resistant prostate cancer
por: Galletti, Giuseppe, et al.
Publicado: (2014) -
Transcriptional Profile Associated with Clinical Outcomes in Metastatic Hormone-Sensitive Prostate Cancer Treated with Androgen Deprivation and Docetaxel
por: Jiménez, Natalia, et al.
Publicado: (2022) -
Enzalutamide for the treatment of metastatic castration-resistant prostate cancer
por: Rodriguez-Vida, Alejo, et al.
Publicado: (2015)